ACP Journal Club: review: apixaban reduces bleeding and mortality compared with vitamin K antagonists.
作者信息
DeLoughery Thomas
出版信息
Ann Intern Med. 2015 Apr 21;162(8):JC2. doi: 10.7326/ACPJC-2015-162-8-002.
PMID:25894047
Abstract
摘要
相似文献
1
ACP Journal Club: review: apixaban reduces bleeding and mortality compared with vitamin K antagonists.《美国内科医师学会杂志俱乐部》综述：与维生素K拮抗剂相比，阿哌沙班可减少出血并降低死亡率。
Ann Intern Med. 2015 Apr 21;162(8):JC2. doi: 10.7326/ACPJC-2015-162-8-002.
2
A meta-analysis of randomized controlled trials of the risk of bleeding with apixaban versus vitamin K antagonists.阿哌沙班与维生素K拮抗剂相比出血风险的随机对照试验的荟萃分析。
Am J Cardiol. 2015 Feb 15;115(4):533-41. doi: 10.1016/j.amjcard.2014.11.039. Epub 2014 Dec 2.
3
ACP Journal Club: review: in renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants.《美国内科医师学会杂志俱乐部》综述：在肾功能损害患者中，与其他抗凝剂相比，阿哌沙班可减少出血或不会增加出血。
Ann Intern Med. 2015 Apr 21;162(8):JC3. doi: 10.7326/ACPJC-2015-162-8-003.
4
Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials.
Int Angiol. 2017 Oct;36(5):496-497. doi: 10.23736/S0392-9590.17.03819-6. Epub 2017 Jun 21.
5
Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin.接受阿哌沙班或华法林治疗的静脉血栓栓塞女性患者的异常阴道出血。
Thromb Haemost. 2017 Apr 3;117(4):809-815. doi: 10.1160/TH16-11-0874. Epub 2017 Feb 9.
6
Bleeding in very old patients on vitamin K antagonist therapy.
Circulation. 2011 Aug 16;124(7):769-71. doi: 10.1161/CIRCULATIONAHA.111.043935.
7
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.阿哌沙班与依诺肝素用于髋或膝关节置换术后血栓预防：来自ADVANCE-2和ADVANCE-3试验的8464例患者主要静脉血栓栓塞和出血的汇总分析
J Bone Joint Surg Br. 2012 Feb;94(2):257-64. doi: 10.1302/0301-620X.94B2.27850.
8
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.阿哌沙班与低分子量肝素/维生素K拮抗剂治疗静脉血栓栓塞症及预防复发的成本效益
BMC Health Serv Res. 2017 Jan 23;17(1):74. doi: 10.1186/s12913-017-1995-8.
9
New oral anticoagulants in elderly patients.老年患者的新型口服抗凝药物。
Best Pract Res Clin Haematol. 2013 Jun;26(2):215-24. doi: 10.1016/j.beha.2013.07.011. Epub 2013 Jul 21.
10
Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism.静脉血栓栓塞症的现代治疗方式及治疗时长
Ther Umsch. 2016;73(10):618-625. doi: 10.1024/0040-5930/a000833.
Zotero 插件